login
register
Home
Getting Started
ChartMill Overview
Growth Traders
Technical Swing Traders
Long Term Investors
Tools
Stock Screener
Stock Charts
Full Screen Stock Charts
Market Monitor
Sectors
Earnings
Analyzer
Insider Trading
Up- and Downgrades
Stock Market
Top Gainers and Losers
New 52 Week High and Low
Gap Up and Gap Down
Most Active
Premarket Movers
After-Hours Movers
Earnings Calendar
USA Market Overview
Canada Market Overview
Europe Market Overview
Trading Ideas
News
Blog
Documentation
Documentation Center
Videos
Indicators
Properties
Screener Market data
Popular Articles
Bull Flags
Relative Strength
Pocket Pivots
Support and Resistance
RSI Indicator
MACD Indicator
Piotroski F-score
Squeeze Plays
Weinstein
Technical Breakout Setups
Trading Tips
Premarket Movers
Gap Up Stocks
Best Dividend Stocks
Bullish Engulfing Pattern
Ascending Triangle Pattern
Swing Trading
All articles ...
Subscriptions
Swing Trading Course
Account
Disclaimer
Affiliate
Contact
Privacy
ELIEM THERAPEUTICS INC (ELYM) Stock News
USA
-
Nasdaq
- NASDAQ:ELYM -
US28658R1068
-
Common Stock
5.11
USD
-0.05 (-0.97%)
Last: 10/2/2024, 8:06:17 PM
5.1
USD
-0.01 (-0.2%)
After Hours:
10/2/2024, 8:06:17 PM
Overview
Stock Chart
Technical Analysis
Fundamental Analysis
Analyst Ratings
Earnings Estimates
Financials
Ownership
News
ELYM Latest News, Press Relases and Analysis
All
Press Releases
a year ago - By: Eliem Therapeutics, Inc.
Eliem Therapeutics Announces Rebranding and Corporate Name Change to Climb Bio, Inc.
a year ago - By: Eliem Therapeutics, Inc.
Eliem Therapeutics Announces Rebranding and Corporate Name Change to Climb Bio, Inc.
a year ago - By: Eliem Therapeutics, Inc.
Eliem Therapeutics to Participate at the Stifel 2024 Virtual Immunology and Inflammation Summit
a year ago - By: Eliem Therapeutics, Inc.
Eliem Therapeutics to Participate at the Stifel 2024 Virtual Immunology and Inflammation Summit
a year ago - By: BusinessInsider
ELYM Stock Earnings: Eliem Therapeutics Reported Results for Q2 2024
a year ago - By: InvestorPlace
ELYM Stock Earnings: Eliem Therapeutics Reported Results for Q2 2024
a year ago - By: Benzinga
- Mentions:
EOSE
AFRM
ARM
STVN
...
Build-A-Bear Workshop Posts Upbeat Earnings, Joins Affirm, Nutanix, Cooper Companies, Veeva Systems And Other Big Stocks Moving Higher On Thursday
a year ago - By: Eliem Therapeutics, Inc.
Eliem Therapeutics Announces Additions to its Leadership Team
a year ago - By: Eliem Therapeutics, Inc.
Eliem Therapeutics Announces Additions to its Leadership Team
a year ago - By: Eliem Therapeutics, Inc.
Eliem Therapeutics Reports Second Quarter Financial Results
a year ago - By: Eliem Therapeutics, Inc.
Eliem Therapeutics Reports Second Quarter Financial Results
2 years ago - By: InvestorPlace
ELYM Stock Earnings: Eliem Therapeutics Reported Results for Q1 2024
2 years ago - By: BusinessInsider
ELYM Stock Earnings: Eliem Therapeutics Reported Results for Q4 2023
a year ago - By: Benzinga
- Mentions:
MNSO
AVAH
SERV
CLW
...
IQVIA Posts Upbeat Earnings, Joins Terex, Reddit And Other Big Stocks Moving Higher On Monday
a year ago - By: Eliem Therapeutics, Inc.
Eliem Therapeutics Announces its Addition to the Russell 2000® and Russell 3000® Indexes
a year ago - By: Eliem Therapeutics, Inc.
Eliem Therapeutics Announces its Addition to the Russell 2000® and Russell 3000® Indexes
a year ago - By: Eliem Therapeutics, Inc.
Eliem Therapeutics Announces the Closing of its Acquisition of Tenet Medicines and Concurrent $120 Million Private Placement
2 years ago - By: InvestorPlace
ELYM Stock Earnings: Eliem Therapeutics Reported Results for Q4 2023
a year ago - By: Eliem Therapeutics, Inc.
Eliem Therapeutics Announces the Closing of its Acquisition of Tenet Medicines and Concurrent $120 Million Private Placement
2 years ago - By: Kaskela Law LLC
SHAREHOLDER ALERT: Kaskela Law LLC Announces Investigation of Eliem Therapeutics, Inc. (ELYM) and Encourages Investors to Contact the Firm
2 years ago - By: Halper Sadeh LLC
ELYM Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Eliem Therapeutics, Inc. Is Fair to Shareholders
2 years ago - By: Eliem Therapeutics, Inc.
Eliem Therapeutics Announces Agreement to Acquire Tenet Medicines and Concurrent $120 Million Private Placement
2 years ago - By: Eliem Therapeutics, Inc.
Eliem Therapeutics Announces Agreement to Acquire Tenet Medicines and Concurrent $120 Million Private Placement
Please enable JavaScript to continue using this application.